Jean-François Ginglinger

Jean-François Ginglinger has been working in the field of biotechnology for over 15 years. Jean-François began their career in 2006 as a Scientific Researcher in Cell and Molecular Biology at the Centre national de la recherche scientifique. In 2013, they moved to Plant Advanced Technologies PAT as a Global R&D Partnerships Manager, where they were responsible for scientific partnerships involving third party companies or academic laboratories. In 2018, they joined Temisis Therapeutics as Chief Scientific Officer. Most recently, in 2021, they were appointed Business Development Manager at Domain Therapeutics.

Jean-François Ginglinger obtained their PhD in Plant Molecular and Cell Biology from the University of Strasbourg in 2010. Prior to that, they obtained an Ingénieur degree in Biotechnology from ENSAIA in 2005.